Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00300742 · ClinicalTrials.gov registry record · Phase 2
Topiramate for the Treatment of Alcohol Dependent Binge-Eating Disordered Individuals
A Phase 2 study, sponsored by University of Virginia.
- Completed
- Registry status
- Phase 2
- Development phase
- 5
- Enrollment target
NCT00300742 is a Phase 2 study that has completed, run by University of Virginia. The registered enrollment target is 5 participants.
The verdict
NCT00300742, a Phase 2 study, has completed, sponsored by University of Virginia.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 5 participants
- Enrollment target
Study Summary
The purpose of this study is to test the feasibility of using topiramate to reduce binge eating and drinking episodes in alcohol dependent individuals with comorbid binge eating disorder.
Interventions
- DRUG Topiramate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2006-03 |
| Est. Completion | 2008-07 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00300742
The ClinicalTrials.gov registry entry for NCT00300742 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Virginia, which has 449 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Topiramate is the first listed.
NCT00300742 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00300742 about?
NCT00300742 is a clinical study titled "Topiramate for the Treatment of Alcohol Dependent Binge-Eating Disordered Individuals". The purpose of this study is to test the feasibility of using topiramate to reduce binge eating and drinking episodes in alcohol dependent individuals with comorbid binge eating disorder.
What is the current status of trial NCT00300742?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 5 participants. The study started on 2006-03. Estimated completion is 2008-07.
What interventions are being tested in trial NCT00300742?
The interventions under investigation include: Topiramate (DRUG).
Who is sponsoring clinical trial NCT00300742?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.